CYTOKINETICS, INCORPORATED Stock Split Ratio
CYTOKINETICS, INCORPORATED (CYTK) reported Stock Split Ratio of 16.70% for the 1-month period ending 2013-06-30, per its 10-K filed 2016-03-03.
Discontinued › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2016-03-03
- 2013-06-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 16.70%; Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month as first filed 100.00%.
- 2013-06-24: Stockholders' Equity Note, Stock Split, Conversion Ratio 16.70%; Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed 100.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 100.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month as first filed |
|---|---|---|---|---|
| 2013-06-30 | 16.70% 10-K · filed 2016-03-03 | 100.00% 10-K · filed 2014-03-07 | ||
| 2013-06-24 | 16.70% 10-K · filed 2016-03-03 | 100.00% 10-Q · filed 2014-08-07 | 100.00% 10-Q · filed 2014-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |